NEW YORK (GenomeWeb News) – Dortmund, Germany-based Protagen today said that it has raised €1 million ($1.5 million) in a third round of financing with private investors.
 
Protagen said it would use the funds to expand its protein biochips business. The firm said it has developed a unique protein biochip technology package, called UNIarray, for the discovery and validation of biomarkers.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.